Free Trial
NASDAQ:AAPG

Ascentage Pharma Group International (AAPG) Stock Price, News & Analysis

Ascentage Pharma Group International logo
$24.31 -0.85 (-3.38%)
As of 05/9/2025 04:00 PM Eastern

About Ascentage Pharma Group International Stock (NASDAQ:AAPG)

Key Stats

Today's Range
$24.19
$24.50
50-Day Range
$17.70
$26.30
52-Week Range
$16.50
$26.50
Volume
9,839 shs
Average Volume
69,148 shs
Market Capitalization
$2.12 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Receive AAPG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter.

AAPG Stock News Headlines

Ascentage Pharma Group International ADR
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More Headlines

AAPG Stock Analysis - Frequently Asked Questions

Ascentage Pharma Group International's stock was trading at $18.67 at the beginning of 2025. Since then, AAPG stock has increased by 30.2% and is now trading at $24.31.
View the best growth stocks for 2025 here
.

Ascentage Pharma Group International (AAPG) raised $126 million in an initial public offering on Friday, January 24th 2025. The company issued 7,325,000 shares at a price of $17.25 per share.

Ascentage Pharma Group International's lock-up period expires on Wednesday, July 23rd. Ascentage Pharma Group International had issued 7,325,000 shares in its IPO on January 24th. The total size of the offering was $126,356,250 based on an initial share price of $17.25. After the expiration of Ascentage Pharma Group International's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

Shares of AAPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AAPG
Previous Symbol
NASDAQ:AAPG
Web
N/A
Fax
N/A
Employees
600
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$980.65 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$2.12 billion
Optionable
N/A
Beta
N/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:AAPG) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners